Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

PCSK9-IN-29

Inquiry
Cat. No.: OB0425LY-215
Synonyms: 1233353-86-0; 2,3,10-Trimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate
Size: 50 mg; 100 mg; 250 mg
CAS No.: 1233353-86-0
Compound CID: 50898972
PCSK9-IN-29

Specification

Description: PCSK9-IN-29 is a selective PCSK9 inhibitor involved in the regulation of cholesterol metabolism.
Formula Weight: 499.55
Applications: PCSK9-IN-29 can be used in studies of non-alcoholic fatty liver disease and obesity.
Storage: Storage at -20°C.
Formula: C26H26FNO6S
Appearance: Solid
Purity: 99.44%, determined by LC-MS.
Solubility: DMSO
Pathway: Metabolic enzyme/Protease
Identity: Confirmed by NMR and LC-MS.
Target: LDLR; PCSK9

Library Information

Solubility: DMSO
Inquiry

Copyright © Protheragen. All rights reserves.